OPtimisation of antiviral Therapy in Immunocompromised COVID-19 patients: a randomized factorial controlled strategy trial: the OPTICOV Study

Authors
Category Primary study
Registry of TrialsClinical Trials Information System
Year 2022
This article has no abstract
Epistemonikos ID: 657ec15bbd50fd1c6b5947a953927867cbb17617
First added on: Oct 02, 2023